Nikita Kotlov
-
- Lymphoma Diagnosis and Treatment 12
- Genetic factors in colorectal cancer 2
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 6
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 3
- Immunology top 10%
-
- Ferroptosis and cancer prognosis 5
Nikita Kotlov
20 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 530
- Oncology 739
- Genetics 226
- Cancer Research 316
- Immunology 342
Countries citing papers authored by Nikita Kotlov
This map shows the geographic impact of Nikita Kotlov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikita Kotlov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikita Kotlov more than expected).
Fields of papers citing papers by Nikita Kotlov
This network shows the impact of papers produced by Nikita Kotlov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikita Kotlov. The network helps show where Nikita Kotlov may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nikita Kotlov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 0 | |
| 14 | 2022 | 0 | |
| 15 | 2021 | 19 | |
| 16 | Conserved pan-cancer microenvironment subtypes predict response to immunotherapybreakdown → | 2021 | 700 |
| 17 | 2021 | 16 | |
| 18 | 2021 | 0 | |
| 19 | A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implicationsbreakdown → | 2020 | 583 |
| 20 | 2020 | 20 |
About Nikita Kotlov
Nikita Kotlov is a scholar working on Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (11 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (5 papers), CAR-T cell therapy research (3 papers), Breast Cancer Treatment Studies (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (530 citations), Oncology (739 citations) and Genetics (226 citations). Nikita Kotlov has collaborated with scholars based in United States, Canada and Russia. Frequent co-authors include Alexander Bagaev, Krystle Nomie, Nathan Fowler, Azamat Gafurov, Maria Tsiper, Ravshan Ataullakhanov, Felix Frenkel, Nava Almog, Olga Gancharova and Viktor Svekolkin. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.